Annie Wong-Beringer, PharmD

Professor of Clinical Pharmacy and Associate Dean for Research

Image of Annie Wong-Beringer, PharmD
Is this your profile? Click to edit

Publications

  • Comparison of phenotypic and genetic traits of ESBL-producing UPEC strains causing recurrent or single episode UTI in postmenopausal women. Ann Clin Microbiol Antimicrob. 2025 Feb 07; 24(1):11.. View in PubMed
  • Prognostic significance of early platelet dynamics in Staphylococcus aureus bacteremia. BMC Infect Dis. 2023 Feb 07; 23(1):82.. View in PubMed
  • Cytokine measurements add value to clinical variables in predicting outcomes for Staphylococcus aureus bacteremia. BMC Infect Dis. 2021 Apr 05; 21(1):317.. View in PubMed
  • Differential effects of antibiotics on neutrophils exposed to lipoteichoic acid derived from Staphylococcus aureus. Ann Clin Microbiol Antimicrob. 2020 Nov 03; 19(1):50.. View in PubMed
  • Utility of qSOFA score in identifying patients at risk for poor outcome in Staphylococcus aureus bacteremia. BMC Infect Dis. 2019 Feb 13; 19(1):149.. View in PubMed
  • Clinically significant bacteria/pyuria-the author responds. Am J Emerg Med. 2017 10; 35(10):1561.. View in PubMed
  • Risk factors for early return visits to the emergency department in patients with urinary tract infection. Am J Emerg Med. 2018 Jan; 36(1):12-17.. View in PubMed
  • Emergency Department Urinary Antibiograms Differ by Specific Patient Group. J Clin Microbiol. 2017 09; 55(9):2629-2636.. View in PubMed
  • Patients presenting to the hospital with MRSA pneumonia: differentiating characteristics and outcomes with empiric treatment. BMC Infect Dis. 2014 May 10; 14:252.. View in PubMed
  • The use of oligonucleotide recombination to generate isogenic mutants of clinical isolates of Pseudomonas aeruginosa. J Microbiol Methods. 2014 Mar; 98:23-5.. View in PubMed
  • Vancomycin-associated nephrotoxicity: a critical appraisal of risk with high-dose therapy. Int J Antimicrob Agents. 2011 Feb; 37(2):95-101.. View in PubMed
  • An antimicrobial stewardship program with a focus on reducing fluoroquinolone overuse. Pharmacotherapy. 2009 Jun; 29(6):736-43.. View in PubMed
  • Comparison of type III secretion system virulence among fluoroquinolone-susceptible and -resistant clinical isolates of Pseudomonas aeruginosa. Clin Microbiol Infect. 2008 Apr; 14(4):330-6.. View in PubMed
  • Suitability of caspofungin for aerosol delivery: physicochemical profiling and nebulizer choice. Chest. 2005 Nov; 128(5):3711-6.. View in PubMed